期刊文献+

胸主动脉瘤和胸主动脉夹层治疗进展 被引量:12

Advances in treatment for thoracic aortic aneurysm and thoracic aortic dissection
原文传递
导出
摘要 胸主动脉瘤和胸主动脉夹层是严重的心血管疾患。胸主动脉瘤和胸主动脉夹层的危险因素包括引起动脉退行性变的因素和增加动脉张力的因素。马凡综合征、Loeys-Dietz综合征、埃-当综合征、主动脉炎症病变、特纳综合征、主动脉二瓣畸形、家族性胸主动脉瘤和胸主动脉夹层等可造成主动脉中膜的变性。高血压、嗜铬细胞瘤、吸毒、外伤、举重、吸烟、心脏手术史等可增加动脉张力或引起动脉损伤。诊断胸主动脉瘤和胸主动脉夹层的主要方法为超声心电图、CT、磁共振。药物治疗包括肾上腺素β受体阻滞药、血管紧张素Ⅱ受体1拮抗药、血管紧张素转换酶抑制药、他汀类药物,对危重患者需行介入治疗或手术治疗。 Thoracic aortic aneurysm and thoracic aortic dissection are severe cardiovascular diseases. The risk factors for thoracic aortic aneurysm and thoracic aortic dissection are conditions that cause the degeneration of aorta and conditions that cause increase of aortic wall stress. Marfan syndrome, Loeye- Dietz syndrome,Ehlers- Danlos syndrome, inflammatory diseases of the aorta, Turner syndrome, bicuspid aortic valve, familial thoracic aortic aneurysm and dissection syndrome may cause aorta medial layer degeneration. Hypertension,pheochromocytoma, cocaine use, trauma, weight lifting, smoking, cardiac surgery may increase aorta wall tension or induce aorta injury. The main methods for diagnosis of thoracic aortic aneurysm and thoracic aortic dissection are echocardiography, computed tomography and cardiac magnetic resonance. Drug treatments include adrenaline beta- blockers, angiotensin Ⅱ receptor 1 antagonists, angiotensin converting enzyme inhibitors,statins. Surgery therapy or interventional therapy is necessary for severe or urgent patients.
作者 黄震华
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2016年第2期122-127,共6页 Chinese Journal of New Drugs and Clinical Remedies
关键词 主动脉 主动脉瘤 动脉瘤 夹层 治疗 aorta thoracic aortic aneurysm aneurysm dissecting therapy
  • 相关文献

参考文献36

  • 1CRIADO FJ.Aortic dissection:a 250-year perspective[J].Tex Heart Inst J,2011,38(6):694-700.
  • 2DAVIS AE,LEWANDOWSKI AJ,HOLLOWAY CJ,et al.Observational study of regional aortic size referenced to body size:production of a cardiovascular magnetic resonance nomogram[J].J Cardiovasc Magn Reson,2014,16(1):9.
  • 3HIRATZKA LF,BAKRIS GL,BECKMAN JA,et al.2010ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease.A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,American Association for Thoracic Surgery,American College of Radiology,American Stroke Association,Society of Cardiovascular Anesthesiologists,Society of Cardiovascular Angiography and Interventions,Society of Interventional Radiology,Society of Thoracic Surgeons,and Society for Vascular Medicine[J].J Am Coll Cardiol,2010,55(14):e27-e129.
  • 4IKONOMIDIS JS,IVEY CR,WHEELER JB,et al.Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease[J].J Thorac Cardiovasc Surg,2013,145(5):1326-1333.
  • 5HOLM TM,HABASHI JP,DOYLE JJ,et al.Noncanonical TGFβsignaling contributes to aortic aneurysm progression in Marfan syndrome mice[J].Science,2011,332(6027):358-361.
  • 6HOWARD DP,BANERJEE A,FAIRHEAD JF,et al.Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control:10-year results from the Oxford Vascular Study[J].Circulation,2013,127(20):2031-2037.
  • 7OLSSON C,THELIN S,STAHLE E,et al.Thoracic aortic aneurysm and dissection:increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14 000 cases from 1987 to 2002[J].Circulation,2006,114(24):2611-2618.
  • 8LOEYS BL,DIETZ HC,BRAVERMAN AC,et al.The revised Ghent nosology for the Marfan syndrome[J].J Med Genet,2010,47(7):476-485.
  • 9LOEYS BL,SCHWARZE U,HOLM T,et al.Aneurysm syndromes caused by mutations in the TGF-beta receptor[J].N Engl J Med,2006,355(8):788-798.
  • 10PEPIN M,SCHWARZE U,SUPERTI-FURGA A,et al.Clinical and genetic features of Ehlers-Danlos syndrome typeⅣ,the vscular type[J].N Engl J Med,2000,342(10):673-680.

同被引文献79

引证文献12

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部